POINT Biopharma Global Inc.
NASDAQ:PNT
12.5 (USD) • At close December 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 226.58 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 |
| Gross Profit
| 226.58 | 0 | 0 | 0 |
| Gross Profit Ratio
| 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 82.05 | 33.505 | 9.142 | 0.001 |
| General & Administrative Expenses
| 19.007 | 12.006 | 3.973 | 0.028 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0.007 |
| SG&A
| 19.007 | 12.006 | 3.973 | 0.035 |
| Other Expenses
| 0 | 0 | 0 | 0 |
| Operating Expenses
| 101.057 | 45.512 | 13.115 | 0.037 |
| Operating Income
| 125.522 | -45.512 | -13.115 | -0.036 |
| Operating Income Ratio
| 0.554 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.064 | -0.085 | -0.17 | -0.001 |
| Income Before Tax
| 129.586 | -45.597 | -13.285 | -0.037 |
| Income Before Tax Ratio
| 0.572 | 0 | 0 | 0 |
| Income Tax Expense
| 31.293 | 0.306 | 0.088 | -0.001 |
| Net Income
| 98.293 | -45.902 | -13.373 | -0.037 |
| Net Income Ratio
| 0.434 | 0 | 0 | 0 |
| EPS
| 1.04 | -0.62 | -0.34 | 0 |
| EPS Diluted
| 1.02 | -0.62 | -0.34 | 0 |
| EBITDA
| 127.323 | -45.512 | -13.115 | -0.001 |
| EBITDA Ratio
| 0.562 | 0 | 0 | 0 |